Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023418 (
leukemia
)
93,477
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
There is increasing evidence that the human lissencephaly-1 gene,
LIS1
, plays an important role in carcinogenesis of several malignancies including
leukemia
. However, little is known about the relationship between single nucleotide polymorphisms (SNPs) in
LIS1
and the susceptibility to myeloid leukemia. In the present study, we systematically screened 5 potentially functional polymorphisms in
LIS1
, and conducted a case-control study including 660 acute myeloid leukemia (AML) patients and 1034 cancer-free controls in a Chinese population, to assess the association between these SNPs and AML risk. We found that the variant alleles of rs4790348, rs4790353, and rs7209748 could significantly increase the AML risk (rs4790348: adjusted OR=1.31, 95%CI=1.13-1.53 in additive model; rs4790353: adjusted OR=4.97, 95%CI=1.59-15.50 in recessive model; rs7209748: adjusted OR=2.34, 95%CI=1.11-4.94 in recessive model). These findings indicated that genetic variants in
LIS1
may contribute to AML risk in Chinese population.
...
PMID:The functional polymorphisms of LIS1 are associated with acute myeloid leukemia risk in a Han Chinese population. 2807 35
<< Previous
1
2
3
4
5
6
7